MedicaidPrior AuthLow impact
Tretten® (Coagulation Factor XIII A-Subunit [Recombinant]) (New)
Humana·OH · Hematology, Pediatrics·Medicaid
Effective date
Feb 1, 2026
We identified it
Jun 24, 2026
Summary
Humana Medicaid Ohio has implemented a new prior authorization requirement for Tretten (Coagulation Factor XIII A-Subunit), effective February 1, 2026. This specialty medication requires prior auth for patients with congenital factor XIII A-subunit deficiency who need routine prophylaxis of bleeding.
Action Required
Before February 1, 2026: Billing team must update prior authorization procedures for Tretten (Coagulation Factor XIII A-Subunit) for Ohio Medicaid patients. Ensure providers document diagnosis of congenital factor XIII A-subunit deficiency and specify use for routine prophylaxis of bleeding when requesting authorization. Note this affects an extremely rare condition (1 in 5 million births).